Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure
NCT00355667 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320
Last updated 2016-08-18
Summary
The purpose of this study is to compare therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in patients with heart failure, and to test our hypothesis that long-acting diuretics are superior to short-acting types in heart failure.
Conditions
- Congestive Heart Failure
Interventions
- DRUG
-
furosemide
Patients with chronic heart failure receive furosemide and other standard treatment/
- DRUG
-
azosemide
Patients with chronic heart failure receive azosemide and other standard treatment.
Sponsors & Collaborators
-
Ministry of Health, Labour and Welfare, Japan
collaborator OTHER_GOV -
Hyogo Medical University
lead OTHER
Principal Investigators
-
Tohru Masuyama, MD, PhD · Cardiovascular Division, Hyogo College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Japan
Study Locations
More Related Trials
-
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF
NCT02649998 ·Status: WITHDRAWN ·Phase: NA
-
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00234104 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure
NCT05940220 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Diuretic Therapy for Acute Decompensated Heart Failure
NCT05840536 ·Status: WITHDRAWN ·Phase: PHASE4
-
Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
NCT00937092 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)
NCT00544869 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00462670 ·Status: COMPLETED ·Phase: PHASE3
-
Acetazolamide in Patients With Acute Heart Failure
NCT03720288 ·Status: UNKNOWN ·Phase: PHASE3
-
Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)
NCT00577135 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00525265 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
NCT01942109 ·Status: UNKNOWN ·Phase: PHASE4
-
Dose-comparison Study of Prednisone in Heart Failure
NCT01559727 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT04628325 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Diuretics Effective Management in Acute Decompensated Heart Failure, EDEMA Trial
NCT03863626 ·Status: UNKNOWN ·Phase: NA
-
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
NCT03730961 ·Status: COMPLETED ·Phase: PHASE2
-
Dopamine in Acute Decompensated Heart Failure II
NCT01060293 ·Status: TERMINATED ·Phase: PHASE4
-
Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients
NCT06535529 ·Status: RECRUITING ·Phase: PHASE3
-
A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
NCT05615363 ·Status: COMPLETED ·Phase: PHASE2
-
Tezosentan in Acute Heart Failure
NCT00525707 ·Status: COMPLETED ·Phase: PHASE3
-
Bumetanide Versus Furosemide in Heart Failure
NCT00372762 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake
NCT03962101 ·Status: COMPLETED ·Phase: PHASE3
-
SGLT2 Inhibition in Combination With Diuretics in Heart Failure
NCT03226457 ·Status: COMPLETED ·Phase: PHASE4
-
ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
NCT00283361 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes
NCT06475105 ·Status: RECRUITING ·Phase: PHASE4
-
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
NCT06625307 ·Status: COMPLETED ·Phase: PHASE1